TD Cowen reinstates coverage on Tempus AI with 'buy' after Ambry deal
TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...
News Medical on MSN1h
New technology unlocks secrets of bacterial gene expression
How do bacteria - harmless ones living in our bodies, or those that cause disease - organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...